Casdin Capital’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.87M | Buy |
1,567,175
+1,200,000
| +327% | +$2.96M | 0.35% | 24 |
|
2025
Q1 | $731K | Hold |
367,175
| – | – | 0.06% | 40 |
|
2024
Q4 | $1.07M | Hold |
367,175
| – | – | 0.07% | 35 |
|
2024
Q3 | $1.42M | Hold |
367,175
| – | – | 0.09% | 31 |
|
2024
Q2 | $1.89M | Hold |
367,175
| – | – | 0.14% | 31 |
|
2024
Q1 | $2.57M | Hold |
367,175
| – | – | 0.19% | 32 |
|
2023
Q4 | $3.25M | Hold |
367,175
| – | – | 0.32% | 29 |
|
2023
Q3 | $3.5M | Hold |
367,175
| – | – | 0.39% | 28 |
|
2023
Q2 | $5.38M | Sell |
367,175
-367,175
| -50% | -$5.38M | 0.47% | 28 |
|
2023
Q1 | $9.03M | Hold |
734,350
| – | – | 0.74% | 30 |
|
2022
Q4 | $13.6M | Buy |
+734,350
| New | +$13.6M | 1.06% | 27 |
|